Company
| Legal Name | argenx SE |
| Headquarters | Boston, United States |
| Website | https://argenx.com |
About Us argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in Belgium, the United States, Japan, and Switzerland. Read More
| Country | City | Job Ads |
|---|---|---|
| Belgium | Gent | 315 |
| Belgium | Ghent | 195 |
| United States | Boston | 77 |
| Switzerland | Zürich | 63 |
| Canada | Toronto | 21 |
| Belgium | European Union | 17 |
| Switzerland | Genf | 11 |
| Canada | Old Toronto | 11 |
| Switzerland | Geneva | 9 |
| United Kingdom | Gerrards Cross | 5 |
Loading map...
Legal Form: SE
Company Type: Beursgenoteerd bedrijf
Company Size: 51 - 250
Job Ads found: 729
Job Ads per Month: 15.2
Hiring Locations: 11
| Date of first job ad | 09.12.2019, 22:19 |
| Date of last job ad | 18.05.2026, 16:08 |
| Date merged | 20.05.2026, 19:26 |
| Date created | 09.12.2019, 22:19 |